Kenneth W. Perry

6.4k total citations
115 papers, 5.2k citations indexed

About

Kenneth W. Perry is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Kenneth W. Perry has authored 115 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Cellular and Molecular Neuroscience, 46 papers in Molecular Biology and 13 papers in Pharmacology. Recurrent topics in Kenneth W. Perry's work include Neurotransmitter Receptor Influence on Behavior (53 papers), Neuroscience and Neuropharmacology Research (47 papers) and Receptor Mechanisms and Signaling (33 papers). Kenneth W. Perry is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (53 papers), Neuroscience and Neuropharmacology Research (47 papers) and Receptor Mechanisms and Signaling (33 papers). Kenneth W. Perry collaborates with scholars based in United States, United Kingdom and Spain. Kenneth W. Perry's co-authors include Ray W. Fuller, Frank P. Bymaster, Bryan B. Molloy, David T. Wong, David T. Wong, Harold D. Snoddy, George G. Nomikos, Eleni T. Tzavara, Craig R. Salhoff and Yvon Delville and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Geochimica et Cosmochimica Acta.

In The Last Decade

Kenneth W. Perry

115 papers receiving 5.1k citations

Peers

Kenneth W. Perry

CMN

PHARM

PMH

Jean‐Michel Rivet France

G. L. Gessa Italy

Edward D. French United States

Svante B. Ross Sweden

John Hyttel Denmark

Roberto William Invernizzi Italy

Edmund Przegaliński Poland

Jørgen Scheel‐Krüger Denmark

David J. Heal United Kingdom

H.C. Fibiger Canada

Jean‐Michel Rivet France

Kenneth W. Perry

3.6k ×1.1

CMN

2.1k ×1.2

694 ×0.7

PHARM

667 ×0.9

PMH

696 ×1.0

Citations per year, relative to Kenneth W. Perry Kenneth W. Perry (= 1×) peers Jean‐Michel Rivet

Countries citing papers authored by Kenneth W. Perry

Since Specialization

Citations

This map shows the geographic impact of Kenneth W. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth W. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth W. Perry more than expected).

Fields of papers citing papers by Kenneth W. Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth W. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth W. Perry. The network helps show where Kenneth W. Perry may publish in the future.

Co-authorship network of co-authors of Kenneth W. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth W. Perry. A scholar is included among the top collaborators of Kenneth W. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth W. Perry. Kenneth W. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fell, Matthew, Gunnar Flik, Joost H.A. Folgering, et al.. (2015). Glutamatergic regulation of brain histamine neurons: In vivo microdialysis and electrophysiology studies in the rat. Neuropharmacology. 99. 1–8. 17 indexed citations

Ortega, Jorge E., Jason Katner, Richard W. Davis, et al.. (2011). Modulation of neurotransmitter release in orexin/hypocretin‐2 receptor knockout mice: A microdialysis study. Journal of Neuroscience Research. 90(3). 588–596. 8 indexed citations

Fell, Matthew, Kenneth W. Perry, Julie F. Falcone, et al.. (2009). In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268). Journal of Pharmacology and Experimental Therapeutics. 331(3). 1126–1136. 31 indexed citations

Fell, Matthew, Jason Katner, Bryan G. Johnson, et al.. (2009). Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge. Neuropharmacology. 58(3). 632–639. 28 indexed citations

Tzavara, Eleni T., Richard J. Davis, Kenneth W. Perry, et al.. (2003). The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. British Journal of Pharmacology. 138(4). 544–553. 231 indexed citations

Swanson, Chad J., Kenneth W. Perry, & Darryle D. Schoepp. (2003). The mGlu2/3 receptor agonist, LY354740, blocks immobilization‐induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex. Journal of Neurochemistry. 88(1). 194–202. 34 indexed citations

Koch, Susanne, Kenneth W. Perry, & Frank P. Bymaster. (2003). Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat. Neuropharmacology. 46(2). 232–242. 57 indexed citations

Perry, Kenneth W., et al.. (2002). Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology. 42(2). 181–190. 133 indexed citations

Tzavara, Eleni T., Kenneth W. Perry, Dana E. Rodriguez, Frank P. Bymaster, & George G. Nomikos. (2001). The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus. European Journal of Pharmacology. 426(3). R3–R4. 62 indexed citations

10.

Perry, Kenneth W., Laura K. Nisenbaum, Carolyn George, et al.. (2001). The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex. Biological Psychiatry. 49(8). 716–725. 39 indexed citations

11.

Cartmell, Jayne, Craig R. Salhoff, Kenneth W. Perry, James A. Monn, & Darryle D. Schoepp. (2000). Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum. Brain Research. 887(2). 378–384. 40 indexed citations

12.

Perry, Kenneth W., et al.. (1999). Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Acta Neurobiologiae Experimentalis. 59(3). 3 indexed citations

13.

Perry, Kenneth W. & Ray W. Fuller. (1997). Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats. Journal of Neural Transmission. 104(8-9). 953–966. 53 indexed citations

14.

Engleman, Eric A., et al.. (1996). Antagonism of Serotonin 5‐HT_1A Receptors Potentiates the Increases in Extracellular Monoamines Induced by Duloxetine in Rat Hypothalamus. Journal of Neurochemistry. 66(2). 599–603. 34 indexed citations

15.

Engleman, Eric A., et al.. (1995). Simultaneous Increases of Extracellular Monoamines in Microdialysates from Hypothalamus of Conscious Rats by Duloxetine, a Dual Serotonin and Norepinephrine Uptake Inhibitor. Neuropsychopharmacology. 12(4). 287–295. 11 indexed citations

16.

Gong, Li, Richard M. Kostrzewa, Ryszard Brus, Ray W. Fuller, & Kenneth W. Perry. (1993). Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. Developmental Brain Research. 76(1). 59–65. 24 indexed citations

17.

Gong, Li, Richard M. Kostrzewa, Ray W. Fuller, & Kenneth W. Perry. (1992). Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1000–1007. 79 indexed citations

18.

Ghetti, Bernardino, Kenneth W. Perry, & Ray W. Fuller. (1988). Serotonin concentration and turnover in cerebelum and other brain regions of pcd mutant mice. Brain Research. 458(2). 367–371. 18 indexed citations

19.

Perry, Kenneth W., et al.. (1988). EFFECT OF PROTEIN INTAKE ON GASTRIN SECRETION IN RUMINANTS. Quarterly Journal of Experimental Physiology. 73(6). 985–993. 7 indexed citations

20.

Perry, Kenneth W.. (1967). Methods of petrologic calculation and the relationship between mineral and bulk chemical composition. Rocky Mountain geology. 6(1). 5–38. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact